EUR UROL 润色咨询

EUROPEAN UROLOGY

出版年份：1975 年文章数：1627 投稿命中率： 开通期刊会员，数据随心看

出版周期：Monthly 自引率：6.6% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=576127, encodeId=dfbc5e61271b, content=不会的<span class="quote">liji_mike 2017-12-30 发表::<br>SCI(2016)：16.265 SCI(2015)：14.976 SCI(2014)：13.938 明年IF是不是要上20了</span><span class="quote">liji_mike 2017-12-30 18:38:00 发表:<br>明年IF是不是要上20了</span>, beContent=liji_mike 2017-12-30 发表:: SCI(2016)：16.265 SCI(2015)：14.976 SCI(2014)：13.938 明年IF是不是要上20了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=306, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/10/b5523b5ebec46ea5fee724ddf46493f2.jpg, createdBy=d68a5183677, createdName=2927405447 威信 实名制科研合作, createdTime=Tue Sep 10 00:00:00 CST 2019, time=2019-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575677, encodeId=69995e5677ab, content=接受个案报道吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=282, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d2d55133358, createdName=白衣书生, createdTime=Sun Sep 01 00:00:00 CST 2019, time=2019-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572655, encodeId=2b485e265586, content=这个杂志是不是不接收完全实验性的研究文章，比如生化分子方面的肾脏学研究, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=216, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210501/1ee9b8a207af40a083f2f4587f995ee7/d7d3bf456666406d83b7a7fa3b9b3f69.jpg, createdBy=ca002563831, createdName=1256b5d0m25暂无昵称, createdTime=Fri Jun 21 00:00:00 CST 2019, time=2019-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554156, encodeId=dfd05541562f, content=写得是什么方向的? <span class="quote">phosphoakt 2018-03-02 发表::<br>研究方向:Prostate cancer;CRPC; 接收率:约50% 审稿时间:约1个月 2017-11-10 Submit 2017-11-26 Revision needed 2017-12-25 Submit Revision 2018-01-09 Revision needed 2018-02-05 Submit Revision 2018-02-13 Accept </span><span class="quote">phosphoakt 2018-03-02 09:10:00 发表:<br>2017-11-10 Submit <br> 2017-11-26 Revision needed <br> 2017-12-25 Submit Revision <br> 2018-01-09 Revision needed <br> 2018-02-05 Submit Revision <br> 2018-02-13 Accept <br> </span>, beContent=phosphoakt 2018-03-02 发表:: 研究方向:Prostate cancer;CRPC; 接收率:约50% 审稿时间:约1个月 2017-11-10 Submit 2017-11-26 Revision needed 2017-12-25 Submit Revision 2018-01-09 Revision needed 2018-02-05 Submit Revision 2018-02-13 Accept , objectType=tool_impact_factor, channel=null, level=null, likeNumber=369, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/249E70925AD389DC8D4E85A35F4AD5EB/100, createdBy=f9401983263, createdName=Hardy-Tau, createdTime=Mon Mar 26 00:00:00 CST 2018, time=2018-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553192, encodeId=1af4553192e3, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：2017-11-10 Submit <br> 2017-11-26 Revision needed <br> 2017-12-25 Submit Revision <br> 2018-01-09 Revision needed <br> 2018-02-05 Submit Revision <br> 2018-02-13 Accept <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=375, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f7ab1630245, createdName=phosphoakt, createdTime=Fri Mar 02 09:10:00 CST 2018, time=2018-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550869, encodeId=d77d5508691d, content=哪位战友知道一审多久吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=445, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/9aLK9Cx6dzdKJ7lWW1cTS61MIc1v1CV2y7jicQ7liaLlkspvBWzGvJrpsicQKxVxuYBnqJysMBlkoI5rtwF2YwCrw/132, createdBy=64631946589, createdName=泌外大主任, createdTime=Sun Jan 07 00:00:00 CST 2018, time=2018-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550487, encodeId=c58d55048e33, content=明年IF是不是要上20了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=326, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/41f5e204935a9288279aa6f69fffe8bc/32e5233dfd4cc36fb9489374ebbfc9e8.jpg, createdBy=ad821409331, createdName=liji_mike, createdTime=Sat Dec 30 18:38:00 CST 2017, time=2017-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544475, encodeId=5fd95444e520, content=谁能预测明年会有多少分?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=407, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=gu_8183, createdTime=Sun Jul 16 19:15:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=496443, encodeId=685c49644399, content=突破十分！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=519, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Jun 20 12:24:00 CST 2013, time=2013-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=493819, encodeId=0e5b4938197d, content=投稿9天就被拒，4个审稿专家，要求确实太高了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=501, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=wangyi, createdTime=Wed Feb 06 17:16:00 CST 2013, time=2013-02-06, status=1, ipAttribution=)]
    2019-09-10 2927405447 威信 实名制科研合作

    不会的liji_mike 2017-12-30 发表::
    SCI(2016)：16.265 SCI(2015)：14.976 SCI(2014)：13.938 明年IF是不是要上20了    liji_mike 2017-12-30 18:38:00 发表:
    明年IF是不是要上20了

    liji_mike 2017-12-30 发表:: SCI(2016)：16.265 SCI(2015)：14.976 SCI(2014)：13.938 明年IF是不是要上20了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=576127, encodeId=dfbc5e61271b, content=不会的<span class="quote">liji_mike 2017-12-30 发表::<br>SCI(2016)：16.265 SCI(2015)：14.976 SCI(2014)：13.938 明年IF是不是要上20了</span><span class="quote">liji_mike 2017-12-30 18:38:00 发表:<br>明年IF是不是要上20了</span>, beContent=liji_mike 2017-12-30 发表:: SCI(2016)：16.265 SCI(2015)：14.976 SCI(2014)：13.938 明年IF是不是要上20了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=306, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/10/b5523b5ebec46ea5fee724ddf46493f2.jpg, createdBy=d68a5183677, createdName=2927405447 威信 实名制科研合作, createdTime=Tue Sep 10 00:00:00 CST 2019, time=2019-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575677, encodeId=69995e5677ab, content=接受个案报道吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=282, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d2d55133358, createdName=白衣书生, createdTime=Sun Sep 01 00:00:00 CST 2019, time=2019-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572655, encodeId=2b485e265586, content=这个杂志是不是不接收完全实验性的研究文章，比如生化分子方面的肾脏学研究, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=216, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210501/1ee9b8a207af40a083f2f4587f995ee7/d7d3bf456666406d83b7a7fa3b9b3f69.jpg, createdBy=ca002563831, createdName=1256b5d0m25暂无昵称, createdTime=Fri Jun 21 00:00:00 CST 2019, time=2019-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554156, encodeId=dfd05541562f, content=写得是什么方向的? <span class="quote">phosphoakt 2018-03-02 发表::<br>研究方向:Prostate cancer;CRPC; 接收率:约50% 审稿时间:约1个月 2017-11-10 Submit 2017-11-26 Revision needed 2017-12-25 Submit Revision 2018-01-09 Revision needed 2018-02-05 Submit Revision 2018-02-13 Accept </span><span class="quote">phosphoakt 2018-03-02 09:10:00 发表:<br>2017-11-10 Submit <br> 2017-11-26 Revision needed <br> 2017-12-25 Submit Revision <br> 2018-01-09 Revision needed <br> 2018-02-05 Submit Revision <br> 2018-02-13 Accept <br> </span>, beContent=phosphoakt 2018-03-02 发表:: 研究方向:Prostate cancer;CRPC; 接收率:约50% 审稿时间:约1个月 2017-11-10 Submit 2017-11-26 Revision needed 2017-12-25 Submit Revision 2018-01-09 Revision needed 2018-02-05 Submit Revision 2018-02-13 Accept , objectType=tool_impact_factor, channel=null, level=null, likeNumber=369, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/249E70925AD389DC8D4E85A35F4AD5EB/100, createdBy=f9401983263, createdName=Hardy-Tau, createdTime=Mon Mar 26 00:00:00 CST 2018, time=2018-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553192, encodeId=1af4553192e3, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：2017-11-10 Submit <br> 2017-11-26 Revision needed <br> 2017-12-25 Submit Revision <br> 2018-01-09 Revision needed <br> 2018-02-05 Submit Revision <br> 2018-02-13 Accept <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=375, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f7ab1630245, createdName=phosphoakt, createdTime=Fri Mar 02 09:10:00 CST 2018, time=2018-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550869, encodeId=d77d5508691d, content=哪位战友知道一审多久吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=445, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/9aLK9Cx6dzdKJ7lWW1cTS61MIc1v1CV2y7jicQ7liaLlkspvBWzGvJrpsicQKxVxuYBnqJysMBlkoI5rtwF2YwCrw/132, createdBy=64631946589, createdName=泌外大主任, createdTime=Sun Jan 07 00:00:00 CST 2018, time=2018-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550487, encodeId=c58d55048e33, content=明年IF是不是要上20了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=326, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/41f5e204935a9288279aa6f69fffe8bc/32e5233dfd4cc36fb9489374ebbfc9e8.jpg, createdBy=ad821409331, createdName=liji_mike, createdTime=Sat Dec 30 18:38:00 CST 2017, time=2017-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544475, encodeId=5fd95444e520, content=谁能预测明年会有多少分?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=407, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=gu_8183, createdTime=Sun Jul 16 19:15:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=496443, encodeId=685c49644399, content=突破十分！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=519, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Jun 20 12:24:00 CST 2013, time=2013-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=493819, encodeId=0e5b4938197d, content=投稿9天就被拒，4个审稿专家，要求确实太高了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=501, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=wangyi, createdTime=Wed Feb 06 17:16:00 CST 2013, time=2013-02-06, status=1, ipAttribution=)]
    2019-09-01 白衣书生

    接受个案报道吗？

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=576127, encodeId=dfbc5e61271b, content=不会的<span class="quote">liji_mike 2017-12-30 发表::<br>SCI(2016)：16.265 SCI(2015)：14.976 SCI(2014)：13.938 明年IF是不是要上20了</span><span class="quote">liji_mike 2017-12-30 18:38:00 发表:<br>明年IF是不是要上20了</span>, beContent=liji_mike 2017-12-30 发表:: SCI(2016)：16.265 SCI(2015)：14.976 SCI(2014)：13.938 明年IF是不是要上20了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=306, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/10/b5523b5ebec46ea5fee724ddf46493f2.jpg, createdBy=d68a5183677, createdName=2927405447 威信 实名制科研合作, createdTime=Tue Sep 10 00:00:00 CST 2019, time=2019-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575677, encodeId=69995e5677ab, content=接受个案报道吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=282, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d2d55133358, createdName=白衣书生, createdTime=Sun Sep 01 00:00:00 CST 2019, time=2019-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572655, encodeId=2b485e265586, content=这个杂志是不是不接收完全实验性的研究文章，比如生化分子方面的肾脏学研究, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=216, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210501/1ee9b8a207af40a083f2f4587f995ee7/d7d3bf456666406d83b7a7fa3b9b3f69.jpg, createdBy=ca002563831, createdName=1256b5d0m25暂无昵称, createdTime=Fri Jun 21 00:00:00 CST 2019, time=2019-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554156, encodeId=dfd05541562f, content=写得是什么方向的? <span class="quote">phosphoakt 2018-03-02 发表::<br>研究方向:Prostate cancer;CRPC; 接收率:约50% 审稿时间:约1个月 2017-11-10 Submit 2017-11-26 Revision needed 2017-12-25 Submit Revision 2018-01-09 Revision needed 2018-02-05 Submit Revision 2018-02-13 Accept </span><span class="quote">phosphoakt 2018-03-02 09:10:00 发表:<br>2017-11-10 Submit <br> 2017-11-26 Revision needed <br> 2017-12-25 Submit Revision <br> 2018-01-09 Revision needed <br> 2018-02-05 Submit Revision <br> 2018-02-13 Accept <br> </span>, beContent=phosphoakt 2018-03-02 发表:: 研究方向:Prostate cancer;CRPC; 接收率:约50% 审稿时间:约1个月 2017-11-10 Submit 2017-11-26 Revision needed 2017-12-25 Submit Revision 2018-01-09 Revision needed 2018-02-05 Submit Revision 2018-02-13 Accept , objectType=tool_impact_factor, channel=null, level=null, likeNumber=369, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/249E70925AD389DC8D4E85A35F4AD5EB/100, createdBy=f9401983263, createdName=Hardy-Tau, createdTime=Mon Mar 26 00:00:00 CST 2018, time=2018-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553192, encodeId=1af4553192e3, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：2017-11-10 Submit <br> 2017-11-26 Revision needed <br> 2017-12-25 Submit Revision <br> 2018-01-09 Revision needed <br> 2018-02-05 Submit Revision <br> 2018-02-13 Accept <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=375, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f7ab1630245, createdName=phosphoakt, createdTime=Fri Mar 02 09:10:00 CST 2018, time=2018-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550869, encodeId=d77d5508691d, content=哪位战友知道一审多久吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=445, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/9aLK9Cx6dzdKJ7lWW1cTS61MIc1v1CV2y7jicQ7liaLlkspvBWzGvJrpsicQKxVxuYBnqJysMBlkoI5rtwF2YwCrw/132, createdBy=64631946589, createdName=泌外大主任, createdTime=Sun Jan 07 00:00:00 CST 2018, time=2018-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550487, encodeId=c58d55048e33, content=明年IF是不是要上20了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=326, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/41f5e204935a9288279aa6f69fffe8bc/32e5233dfd4cc36fb9489374ebbfc9e8.jpg, createdBy=ad821409331, createdName=liji_mike, createdTime=Sat Dec 30 18:38:00 CST 2017, time=2017-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544475, encodeId=5fd95444e520, content=谁能预测明年会有多少分?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=407, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=gu_8183, createdTime=Sun Jul 16 19:15:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=496443, encodeId=685c49644399, content=突破十分！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=519, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Jun 20 12:24:00 CST 2013, time=2013-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=493819, encodeId=0e5b4938197d, content=投稿9天就被拒，4个审稿专家，要求确实太高了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=501, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=wangyi, createdTime=Wed Feb 06 17:16:00 CST 2013, time=2013-02-06, status=1, ipAttribution=)]
    2019-06-21 1256b5d0m25暂无昵称

    这个杂志是不是不接收完全实验性的研究文章，比如生化分子方面的肾脏学研究

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=576127, encodeId=dfbc5e61271b, content=不会的<span class="quote">liji_mike 2017-12-30 发表::<br>SCI(2016)：16.265 SCI(2015)：14.976 SCI(2014)：13.938 明年IF是不是要上20了</span><span class="quote">liji_mike 2017-12-30 18:38:00 发表:<br>明年IF是不是要上20了</span>, beContent=liji_mike 2017-12-30 发表:: SCI(2016)：16.265 SCI(2015)：14.976 SCI(2014)：13.938 明年IF是不是要上20了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=306, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/10/b5523b5ebec46ea5fee724ddf46493f2.jpg, createdBy=d68a5183677, createdName=2927405447 威信 实名制科研合作, createdTime=Tue Sep 10 00:00:00 CST 2019, time=2019-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575677, encodeId=69995e5677ab, content=接受个案报道吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=282, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d2d55133358, createdName=白衣书生, createdTime=Sun Sep 01 00:00:00 CST 2019, time=2019-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572655, encodeId=2b485e265586, content=这个杂志是不是不接收完全实验性的研究文章，比如生化分子方面的肾脏学研究, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=216, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210501/1ee9b8a207af40a083f2f4587f995ee7/d7d3bf456666406d83b7a7fa3b9b3f69.jpg, createdBy=ca002563831, createdName=1256b5d0m25暂无昵称, createdTime=Fri Jun 21 00:00:00 CST 2019, time=2019-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554156, encodeId=dfd05541562f, content=写得是什么方向的? <span class="quote">phosphoakt 2018-03-02 发表::<br>研究方向:Prostate cancer;CRPC; 接收率:约50% 审稿时间:约1个月 2017-11-10 Submit 2017-11-26 Revision needed 2017-12-25 Submit Revision 2018-01-09 Revision needed 2018-02-05 Submit Revision 2018-02-13 Accept </span><span class="quote">phosphoakt 2018-03-02 09:10:00 发表:<br>2017-11-10 Submit <br> 2017-11-26 Revision needed <br> 2017-12-25 Submit Revision <br> 2018-01-09 Revision needed <br> 2018-02-05 Submit Revision <br> 2018-02-13 Accept <br> </span>, beContent=phosphoakt 2018-03-02 发表:: 研究方向:Prostate cancer;CRPC; 接收率:约50% 审稿时间:约1个月 2017-11-10 Submit 2017-11-26 Revision needed 2017-12-25 Submit Revision 2018-01-09 Revision needed 2018-02-05 Submit Revision 2018-02-13 Accept , objectType=tool_impact_factor, channel=null, level=null, likeNumber=369, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/249E70925AD389DC8D4E85A35F4AD5EB/100, createdBy=f9401983263, createdName=Hardy-Tau, createdTime=Mon Mar 26 00:00:00 CST 2018, time=2018-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553192, encodeId=1af4553192e3, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：2017-11-10 Submit <br> 2017-11-26 Revision needed <br> 2017-12-25 Submit Revision <br> 2018-01-09 Revision needed <br> 2018-02-05 Submit Revision <br> 2018-02-13 Accept <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=375, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f7ab1630245, createdName=phosphoakt, createdTime=Fri Mar 02 09:10:00 CST 2018, time=2018-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550869, encodeId=d77d5508691d, content=哪位战友知道一审多久吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=445, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/9aLK9Cx6dzdKJ7lWW1cTS61MIc1v1CV2y7jicQ7liaLlkspvBWzGvJrpsicQKxVxuYBnqJysMBlkoI5rtwF2YwCrw/132, createdBy=64631946589, createdName=泌外大主任, createdTime=Sun Jan 07 00:00:00 CST 2018, time=2018-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550487, encodeId=c58d55048e33, content=明年IF是不是要上20了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=326, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/41f5e204935a9288279aa6f69fffe8bc/32e5233dfd4cc36fb9489374ebbfc9e8.jpg, createdBy=ad821409331, createdName=liji_mike, createdTime=Sat Dec 30 18:38:00 CST 2017, time=2017-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544475, encodeId=5fd95444e520, content=谁能预测明年会有多少分?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=407, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=gu_8183, createdTime=Sun Jul 16 19:15:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=496443, encodeId=685c49644399, content=突破十分！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=519, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Jun 20 12:24:00 CST 2013, time=2013-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=493819, encodeId=0e5b4938197d, content=投稿9天就被拒，4个审稿专家，要求确实太高了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=501, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=wangyi, createdTime=Wed Feb 06 17:16:00 CST 2013, time=2013-02-06, status=1, ipAttribution=)]
    2018-03-26 Hardy-Tau

    写得是什么方向的? phosphoakt 2018-03-02 发表::
    研究方向:Prostate cancer;CRPC; 接收率:约50% 审稿时间:约1个月 2017-11-10 Submit 2017-11-26 Revision needed 2017-12-25 Submit Revision 2018-01-09 Revision needed 2018-02-05 Submit Revision 2018-02-13 Accept     phosphoakt 2018-03-02 09:10:00 发表:
    2017-11-10 Submit
    2017-11-26 Revision needed
    2017-12-25 Submit Revision
    2018-01-09 Revision needed
    2018-02-05 Submit Revision
    2018-02-13 Accept

    phosphoakt 2018-03-02 发表:: 研究方向:Prostate cancer;CRPC; 接收率:约50% 审稿时间:约1个月 2017-11-10 Submit 2017-11-26 Revision needed 2017-12-25 Submit Revision 2018-01-09 Revision needed 2018-02-05 Submit Revision 2018-02-13 Accept

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=576127, encodeId=dfbc5e61271b, content=不会的<span class="quote">liji_mike 2017-12-30 发表::<br>SCI(2016)：16.265 SCI(2015)：14.976 SCI(2014)：13.938 明年IF是不是要上20了</span><span class="quote">liji_mike 2017-12-30 18:38:00 发表:<br>明年IF是不是要上20了</span>, beContent=liji_mike 2017-12-30 发表:: SCI(2016)：16.265 SCI(2015)：14.976 SCI(2014)：13.938 明年IF是不是要上20了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=306, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/10/b5523b5ebec46ea5fee724ddf46493f2.jpg, createdBy=d68a5183677, createdName=2927405447 威信 实名制科研合作, createdTime=Tue Sep 10 00:00:00 CST 2019, time=2019-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575677, encodeId=69995e5677ab, content=接受个案报道吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=282, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d2d55133358, createdName=白衣书生, createdTime=Sun Sep 01 00:00:00 CST 2019, time=2019-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572655, encodeId=2b485e265586, content=这个杂志是不是不接收完全实验性的研究文章，比如生化分子方面的肾脏学研究, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=216, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210501/1ee9b8a207af40a083f2f4587f995ee7/d7d3bf456666406d83b7a7fa3b9b3f69.jpg, createdBy=ca002563831, createdName=1256b5d0m25暂无昵称, createdTime=Fri Jun 21 00:00:00 CST 2019, time=2019-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554156, encodeId=dfd05541562f, content=写得是什么方向的? <span class="quote">phosphoakt 2018-03-02 发表::<br>研究方向:Prostate cancer;CRPC; 接收率:约50% 审稿时间:约1个月 2017-11-10 Submit 2017-11-26 Revision needed 2017-12-25 Submit Revision 2018-01-09 Revision needed 2018-02-05 Submit Revision 2018-02-13 Accept </span><span class="quote">phosphoakt 2018-03-02 09:10:00 发表:<br>2017-11-10 Submit <br> 2017-11-26 Revision needed <br> 2017-12-25 Submit Revision <br> 2018-01-09 Revision needed <br> 2018-02-05 Submit Revision <br> 2018-02-13 Accept <br> </span>, beContent=phosphoakt 2018-03-02 发表:: 研究方向:Prostate cancer;CRPC; 接收率:约50% 审稿时间:约1个月 2017-11-10 Submit 2017-11-26 Revision needed 2017-12-25 Submit Revision 2018-01-09 Revision needed 2018-02-05 Submit Revision 2018-02-13 Accept , objectType=tool_impact_factor, channel=null, level=null, likeNumber=369, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/249E70925AD389DC8D4E85A35F4AD5EB/100, createdBy=f9401983263, createdName=Hardy-Tau, createdTime=Mon Mar 26 00:00:00 CST 2018, time=2018-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553192, encodeId=1af4553192e3, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：2017-11-10 Submit <br> 2017-11-26 Revision needed <br> 2017-12-25 Submit Revision <br> 2018-01-09 Revision needed <br> 2018-02-05 Submit Revision <br> 2018-02-13 Accept <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=375, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f7ab1630245, createdName=phosphoakt, createdTime=Fri Mar 02 09:10:00 CST 2018, time=2018-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550869, encodeId=d77d5508691d, content=哪位战友知道一审多久吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=445, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/9aLK9Cx6dzdKJ7lWW1cTS61MIc1v1CV2y7jicQ7liaLlkspvBWzGvJrpsicQKxVxuYBnqJysMBlkoI5rtwF2YwCrw/132, createdBy=64631946589, createdName=泌外大主任, createdTime=Sun Jan 07 00:00:00 CST 2018, time=2018-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550487, encodeId=c58d55048e33, content=明年IF是不是要上20了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=326, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/41f5e204935a9288279aa6f69fffe8bc/32e5233dfd4cc36fb9489374ebbfc9e8.jpg, createdBy=ad821409331, createdName=liji_mike, createdTime=Sat Dec 30 18:38:00 CST 2017, time=2017-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544475, encodeId=5fd95444e520, content=谁能预测明年会有多少分?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=407, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=gu_8183, createdTime=Sun Jul 16 19:15:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=496443, encodeId=685c49644399, content=突破十分！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=519, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Jun 20 12:24:00 CST 2013, time=2013-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=493819, encodeId=0e5b4938197d, content=投稿9天就被拒，4个审稿专家，要求确实太高了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=501, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=wangyi, createdTime=Wed Feb 06 17:16:00 CST 2013, time=2013-02-06, status=1, ipAttribution=)]
    2018-03-02 phosphoakt

    审稿速度:1.0 | 投稿命中率:50.0
    经验分享：2017-11-10 Submit
    2017-11-26 Revision needed
    2017-12-25 Submit Revision
    2018-01-09 Revision needed
    2018-02-05 Submit Revision
    2018-02-13 Accept

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=576127, encodeId=dfbc5e61271b, content=不会的<span class="quote">liji_mike 2017-12-30 发表::<br>SCI(2016)：16.265 SCI(2015)：14.976 SCI(2014)：13.938 明年IF是不是要上20了</span><span class="quote">liji_mike 2017-12-30 18:38:00 发表:<br>明年IF是不是要上20了</span>, beContent=liji_mike 2017-12-30 发表:: SCI(2016)：16.265 SCI(2015)：14.976 SCI(2014)：13.938 明年IF是不是要上20了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=306, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/10/b5523b5ebec46ea5fee724ddf46493f2.jpg, createdBy=d68a5183677, createdName=2927405447 威信 实名制科研合作, createdTime=Tue Sep 10 00:00:00 CST 2019, time=2019-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575677, encodeId=69995e5677ab, content=接受个案报道吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=282, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d2d55133358, createdName=白衣书生, createdTime=Sun Sep 01 00:00:00 CST 2019, time=2019-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572655, encodeId=2b485e265586, content=这个杂志是不是不接收完全实验性的研究文章，比如生化分子方面的肾脏学研究, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=216, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210501/1ee9b8a207af40a083f2f4587f995ee7/d7d3bf456666406d83b7a7fa3b9b3f69.jpg, createdBy=ca002563831, createdName=1256b5d0m25暂无昵称, createdTime=Fri Jun 21 00:00:00 CST 2019, time=2019-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554156, encodeId=dfd05541562f, content=写得是什么方向的? <span class="quote">phosphoakt 2018-03-02 发表::<br>研究方向:Prostate cancer;CRPC; 接收率:约50% 审稿时间:约1个月 2017-11-10 Submit 2017-11-26 Revision needed 2017-12-25 Submit Revision 2018-01-09 Revision needed 2018-02-05 Submit Revision 2018-02-13 Accept </span><span class="quote">phosphoakt 2018-03-02 09:10:00 发表:<br>2017-11-10 Submit <br> 2017-11-26 Revision needed <br> 2017-12-25 Submit Revision <br> 2018-01-09 Revision needed <br> 2018-02-05 Submit Revision <br> 2018-02-13 Accept <br> </span>, beContent=phosphoakt 2018-03-02 发表:: 研究方向:Prostate cancer;CRPC; 接收率:约50% 审稿时间:约1个月 2017-11-10 Submit 2017-11-26 Revision needed 2017-12-25 Submit Revision 2018-01-09 Revision needed 2018-02-05 Submit Revision 2018-02-13 Accept , objectType=tool_impact_factor, channel=null, level=null, likeNumber=369, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/249E70925AD389DC8D4E85A35F4AD5EB/100, createdBy=f9401983263, createdName=Hardy-Tau, createdTime=Mon Mar 26 00:00:00 CST 2018, time=2018-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553192, encodeId=1af4553192e3, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：2017-11-10 Submit <br> 2017-11-26 Revision needed <br> 2017-12-25 Submit Revision <br> 2018-01-09 Revision needed <br> 2018-02-05 Submit Revision <br> 2018-02-13 Accept <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=375, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f7ab1630245, createdName=phosphoakt, createdTime=Fri Mar 02 09:10:00 CST 2018, time=2018-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550869, encodeId=d77d5508691d, content=哪位战友知道一审多久吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=445, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/9aLK9Cx6dzdKJ7lWW1cTS61MIc1v1CV2y7jicQ7liaLlkspvBWzGvJrpsicQKxVxuYBnqJysMBlkoI5rtwF2YwCrw/132, createdBy=64631946589, createdName=泌外大主任, createdTime=Sun Jan 07 00:00:00 CST 2018, time=2018-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550487, encodeId=c58d55048e33, content=明年IF是不是要上20了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=326, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/41f5e204935a9288279aa6f69fffe8bc/32e5233dfd4cc36fb9489374ebbfc9e8.jpg, createdBy=ad821409331, createdName=liji_mike, createdTime=Sat Dec 30 18:38:00 CST 2017, time=2017-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544475, encodeId=5fd95444e520, content=谁能预测明年会有多少分?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=407, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=gu_8183, createdTime=Sun Jul 16 19:15:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=496443, encodeId=685c49644399, content=突破十分！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=519, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Jun 20 12:24:00 CST 2013, time=2013-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=493819, encodeId=0e5b4938197d, content=投稿9天就被拒，4个审稿专家，要求确实太高了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=501, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=wangyi, createdTime=Wed Feb 06 17:16:00 CST 2013, time=2013-02-06, status=1, ipAttribution=)]
    2018-01-07 泌外大主任

    哪位战友知道一审多久吗?

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=576127, encodeId=dfbc5e61271b, content=不会的<span class="quote">liji_mike 2017-12-30 发表::<br>SCI(2016)：16.265 SCI(2015)：14.976 SCI(2014)：13.938 明年IF是不是要上20了</span><span class="quote">liji_mike 2017-12-30 18:38:00 发表:<br>明年IF是不是要上20了</span>, beContent=liji_mike 2017-12-30 发表:: SCI(2016)：16.265 SCI(2015)：14.976 SCI(2014)：13.938 明年IF是不是要上20了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=306, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/10/b5523b5ebec46ea5fee724ddf46493f2.jpg, createdBy=d68a5183677, createdName=2927405447 威信 实名制科研合作, createdTime=Tue Sep 10 00:00:00 CST 2019, time=2019-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575677, encodeId=69995e5677ab, content=接受个案报道吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=282, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d2d55133358, createdName=白衣书生, createdTime=Sun Sep 01 00:00:00 CST 2019, time=2019-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572655, encodeId=2b485e265586, content=这个杂志是不是不接收完全实验性的研究文章，比如生化分子方面的肾脏学研究, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=216, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210501/1ee9b8a207af40a083f2f4587f995ee7/d7d3bf456666406d83b7a7fa3b9b3f69.jpg, createdBy=ca002563831, createdName=1256b5d0m25暂无昵称, createdTime=Fri Jun 21 00:00:00 CST 2019, time=2019-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554156, encodeId=dfd05541562f, content=写得是什么方向的? <span class="quote">phosphoakt 2018-03-02 发表::<br>研究方向:Prostate cancer;CRPC; 接收率:约50% 审稿时间:约1个月 2017-11-10 Submit 2017-11-26 Revision needed 2017-12-25 Submit Revision 2018-01-09 Revision needed 2018-02-05 Submit Revision 2018-02-13 Accept </span><span class="quote">phosphoakt 2018-03-02 09:10:00 发表:<br>2017-11-10 Submit <br> 2017-11-26 Revision needed <br> 2017-12-25 Submit Revision <br> 2018-01-09 Revision needed <br> 2018-02-05 Submit Revision <br> 2018-02-13 Accept <br> </span>, beContent=phosphoakt 2018-03-02 发表:: 研究方向:Prostate cancer;CRPC; 接收率:约50% 审稿时间:约1个月 2017-11-10 Submit 2017-11-26 Revision needed 2017-12-25 Submit Revision 2018-01-09 Revision needed 2018-02-05 Submit Revision 2018-02-13 Accept , objectType=tool_impact_factor, channel=null, level=null, likeNumber=369, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/249E70925AD389DC8D4E85A35F4AD5EB/100, createdBy=f9401983263, createdName=Hardy-Tau, createdTime=Mon Mar 26 00:00:00 CST 2018, time=2018-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553192, encodeId=1af4553192e3, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：2017-11-10 Submit <br> 2017-11-26 Revision needed <br> 2017-12-25 Submit Revision <br> 2018-01-09 Revision needed <br> 2018-02-05 Submit Revision <br> 2018-02-13 Accept <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=375, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f7ab1630245, createdName=phosphoakt, createdTime=Fri Mar 02 09:10:00 CST 2018, time=2018-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550869, encodeId=d77d5508691d, content=哪位战友知道一审多久吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=445, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/9aLK9Cx6dzdKJ7lWW1cTS61MIc1v1CV2y7jicQ7liaLlkspvBWzGvJrpsicQKxVxuYBnqJysMBlkoI5rtwF2YwCrw/132, createdBy=64631946589, createdName=泌外大主任, createdTime=Sun Jan 07 00:00:00 CST 2018, time=2018-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550487, encodeId=c58d55048e33, content=明年IF是不是要上20了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=326, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/41f5e204935a9288279aa6f69fffe8bc/32e5233dfd4cc36fb9489374ebbfc9e8.jpg, createdBy=ad821409331, createdName=liji_mike, createdTime=Sat Dec 30 18:38:00 CST 2017, time=2017-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544475, encodeId=5fd95444e520, content=谁能预测明年会有多少分?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=407, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=gu_8183, createdTime=Sun Jul 16 19:15:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=496443, encodeId=685c49644399, content=突破十分！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=519, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Jun 20 12:24:00 CST 2013, time=2013-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=493819, encodeId=0e5b4938197d, content=投稿9天就被拒，4个审稿专家，要求确实太高了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=501, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=wangyi, createdTime=Wed Feb 06 17:16:00 CST 2013, time=2013-02-06, status=1, ipAttribution=)]
    2017-12-30 liji_mike

    明年IF是不是要上20了

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=576127, encodeId=dfbc5e61271b, content=不会的<span class="quote">liji_mike 2017-12-30 发表::<br>SCI(2016)：16.265 SCI(2015)：14.976 SCI(2014)：13.938 明年IF是不是要上20了</span><span class="quote">liji_mike 2017-12-30 18:38:00 发表:<br>明年IF是不是要上20了</span>, beContent=liji_mike 2017-12-30 发表:: SCI(2016)：16.265 SCI(2015)：14.976 SCI(2014)：13.938 明年IF是不是要上20了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=306, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/10/b5523b5ebec46ea5fee724ddf46493f2.jpg, createdBy=d68a5183677, createdName=2927405447 威信 实名制科研合作, createdTime=Tue Sep 10 00:00:00 CST 2019, time=2019-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575677, encodeId=69995e5677ab, content=接受个案报道吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=282, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d2d55133358, createdName=白衣书生, createdTime=Sun Sep 01 00:00:00 CST 2019, time=2019-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572655, encodeId=2b485e265586, content=这个杂志是不是不接收完全实验性的研究文章，比如生化分子方面的肾脏学研究, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=216, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210501/1ee9b8a207af40a083f2f4587f995ee7/d7d3bf456666406d83b7a7fa3b9b3f69.jpg, createdBy=ca002563831, createdName=1256b5d0m25暂无昵称, createdTime=Fri Jun 21 00:00:00 CST 2019, time=2019-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554156, encodeId=dfd05541562f, content=写得是什么方向的? <span class="quote">phosphoakt 2018-03-02 发表::<br>研究方向:Prostate cancer;CRPC; 接收率:约50% 审稿时间:约1个月 2017-11-10 Submit 2017-11-26 Revision needed 2017-12-25 Submit Revision 2018-01-09 Revision needed 2018-02-05 Submit Revision 2018-02-13 Accept </span><span class="quote">phosphoakt 2018-03-02 09:10:00 发表:<br>2017-11-10 Submit <br> 2017-11-26 Revision needed <br> 2017-12-25 Submit Revision <br> 2018-01-09 Revision needed <br> 2018-02-05 Submit Revision <br> 2018-02-13 Accept <br> </span>, beContent=phosphoakt 2018-03-02 发表:: 研究方向:Prostate cancer;CRPC; 接收率:约50% 审稿时间:约1个月 2017-11-10 Submit 2017-11-26 Revision needed 2017-12-25 Submit Revision 2018-01-09 Revision needed 2018-02-05 Submit Revision 2018-02-13 Accept , objectType=tool_impact_factor, channel=null, level=null, likeNumber=369, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/249E70925AD389DC8D4E85A35F4AD5EB/100, createdBy=f9401983263, createdName=Hardy-Tau, createdTime=Mon Mar 26 00:00:00 CST 2018, time=2018-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553192, encodeId=1af4553192e3, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：2017-11-10 Submit <br> 2017-11-26 Revision needed <br> 2017-12-25 Submit Revision <br> 2018-01-09 Revision needed <br> 2018-02-05 Submit Revision <br> 2018-02-13 Accept <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=375, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f7ab1630245, createdName=phosphoakt, createdTime=Fri Mar 02 09:10:00 CST 2018, time=2018-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550869, encodeId=d77d5508691d, content=哪位战友知道一审多久吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=445, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/9aLK9Cx6dzdKJ7lWW1cTS61MIc1v1CV2y7jicQ7liaLlkspvBWzGvJrpsicQKxVxuYBnqJysMBlkoI5rtwF2YwCrw/132, createdBy=64631946589, createdName=泌外大主任, createdTime=Sun Jan 07 00:00:00 CST 2018, time=2018-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550487, encodeId=c58d55048e33, content=明年IF是不是要上20了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=326, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/41f5e204935a9288279aa6f69fffe8bc/32e5233dfd4cc36fb9489374ebbfc9e8.jpg, createdBy=ad821409331, createdName=liji_mike, createdTime=Sat Dec 30 18:38:00 CST 2017, time=2017-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544475, encodeId=5fd95444e520, content=谁能预测明年会有多少分?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=407, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=gu_8183, createdTime=Sun Jul 16 19:15:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=496443, encodeId=685c49644399, content=突破十分！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=519, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Jun 20 12:24:00 CST 2013, time=2013-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=493819, encodeId=0e5b4938197d, content=投稿9天就被拒，4个审稿专家，要求确实太高了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=501, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=wangyi, createdTime=Wed Feb 06 17:16:00 CST 2013, time=2013-02-06, status=1, ipAttribution=)]
    2017-07-16 gu_8183

    谁能预测明年会有多少分?

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=576127, encodeId=dfbc5e61271b, content=不会的<span class="quote">liji_mike 2017-12-30 发表::<br>SCI(2016)：16.265 SCI(2015)：14.976 SCI(2014)：13.938 明年IF是不是要上20了</span><span class="quote">liji_mike 2017-12-30 18:38:00 发表:<br>明年IF是不是要上20了</span>, beContent=liji_mike 2017-12-30 发表:: SCI(2016)：16.265 SCI(2015)：14.976 SCI(2014)：13.938 明年IF是不是要上20了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=306, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/10/b5523b5ebec46ea5fee724ddf46493f2.jpg, createdBy=d68a5183677, createdName=2927405447 威信 实名制科研合作, createdTime=Tue Sep 10 00:00:00 CST 2019, time=2019-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575677, encodeId=69995e5677ab, content=接受个案报道吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=282, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d2d55133358, createdName=白衣书生, createdTime=Sun Sep 01 00:00:00 CST 2019, time=2019-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572655, encodeId=2b485e265586, content=这个杂志是不是不接收完全实验性的研究文章，比如生化分子方面的肾脏学研究, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=216, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210501/1ee9b8a207af40a083f2f4587f995ee7/d7d3bf456666406d83b7a7fa3b9b3f69.jpg, createdBy=ca002563831, createdName=1256b5d0m25暂无昵称, createdTime=Fri Jun 21 00:00:00 CST 2019, time=2019-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554156, encodeId=dfd05541562f, content=写得是什么方向的? <span class="quote">phosphoakt 2018-03-02 发表::<br>研究方向:Prostate cancer;CRPC; 接收率:约50% 审稿时间:约1个月 2017-11-10 Submit 2017-11-26 Revision needed 2017-12-25 Submit Revision 2018-01-09 Revision needed 2018-02-05 Submit Revision 2018-02-13 Accept </span><span class="quote">phosphoakt 2018-03-02 09:10:00 发表:<br>2017-11-10 Submit <br> 2017-11-26 Revision needed <br> 2017-12-25 Submit Revision <br> 2018-01-09 Revision needed <br> 2018-02-05 Submit Revision <br> 2018-02-13 Accept <br> </span>, beContent=phosphoakt 2018-03-02 发表:: 研究方向:Prostate cancer;CRPC; 接收率:约50% 审稿时间:约1个月 2017-11-10 Submit 2017-11-26 Revision needed 2017-12-25 Submit Revision 2018-01-09 Revision needed 2018-02-05 Submit Revision 2018-02-13 Accept , objectType=tool_impact_factor, channel=null, level=null, likeNumber=369, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/249E70925AD389DC8D4E85A35F4AD5EB/100, createdBy=f9401983263, createdName=Hardy-Tau, createdTime=Mon Mar 26 00:00:00 CST 2018, time=2018-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553192, encodeId=1af4553192e3, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：2017-11-10 Submit <br> 2017-11-26 Revision needed <br> 2017-12-25 Submit Revision <br> 2018-01-09 Revision needed <br> 2018-02-05 Submit Revision <br> 2018-02-13 Accept <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=375, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f7ab1630245, createdName=phosphoakt, createdTime=Fri Mar 02 09:10:00 CST 2018, time=2018-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550869, encodeId=d77d5508691d, content=哪位战友知道一审多久吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=445, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/9aLK9Cx6dzdKJ7lWW1cTS61MIc1v1CV2y7jicQ7liaLlkspvBWzGvJrpsicQKxVxuYBnqJysMBlkoI5rtwF2YwCrw/132, createdBy=64631946589, createdName=泌外大主任, createdTime=Sun Jan 07 00:00:00 CST 2018, time=2018-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550487, encodeId=c58d55048e33, content=明年IF是不是要上20了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=326, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/41f5e204935a9288279aa6f69fffe8bc/32e5233dfd4cc36fb9489374ebbfc9e8.jpg, createdBy=ad821409331, createdName=liji_mike, createdTime=Sat Dec 30 18:38:00 CST 2017, time=2017-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544475, encodeId=5fd95444e520, content=谁能预测明年会有多少分?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=407, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=gu_8183, createdTime=Sun Jul 16 19:15:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=496443, encodeId=685c49644399, content=突破十分！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=519, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Jun 20 12:24:00 CST 2013, time=2013-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=493819, encodeId=0e5b4938197d, content=投稿9天就被拒，4个审稿专家，要求确实太高了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=501, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=wangyi, createdTime=Wed Feb 06 17:16:00 CST 2013, time=2013-02-06, status=1, ipAttribution=)]
    2013-06-20 匿名用户

    突破十分！

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=576127, encodeId=dfbc5e61271b, content=不会的<span class="quote">liji_mike 2017-12-30 发表::<br>SCI(2016)：16.265 SCI(2015)：14.976 SCI(2014)：13.938 明年IF是不是要上20了</span><span class="quote">liji_mike 2017-12-30 18:38:00 发表:<br>明年IF是不是要上20了</span>, beContent=liji_mike 2017-12-30 发表:: SCI(2016)：16.265 SCI(2015)：14.976 SCI(2014)：13.938 明年IF是不是要上20了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=306, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/10/b5523b5ebec46ea5fee724ddf46493f2.jpg, createdBy=d68a5183677, createdName=2927405447 威信 实名制科研合作, createdTime=Tue Sep 10 00:00:00 CST 2019, time=2019-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575677, encodeId=69995e5677ab, content=接受个案报道吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=282, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d2d55133358, createdName=白衣书生, createdTime=Sun Sep 01 00:00:00 CST 2019, time=2019-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572655, encodeId=2b485e265586, content=这个杂志是不是不接收完全实验性的研究文章，比如生化分子方面的肾脏学研究, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=216, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210501/1ee9b8a207af40a083f2f4587f995ee7/d7d3bf456666406d83b7a7fa3b9b3f69.jpg, createdBy=ca002563831, createdName=1256b5d0m25暂无昵称, createdTime=Fri Jun 21 00:00:00 CST 2019, time=2019-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554156, encodeId=dfd05541562f, content=写得是什么方向的? <span class="quote">phosphoakt 2018-03-02 发表::<br>研究方向:Prostate cancer;CRPC; 接收率:约50% 审稿时间:约1个月 2017-11-10 Submit 2017-11-26 Revision needed 2017-12-25 Submit Revision 2018-01-09 Revision needed 2018-02-05 Submit Revision 2018-02-13 Accept </span><span class="quote">phosphoakt 2018-03-02 09:10:00 发表:<br>2017-11-10 Submit <br> 2017-11-26 Revision needed <br> 2017-12-25 Submit Revision <br> 2018-01-09 Revision needed <br> 2018-02-05 Submit Revision <br> 2018-02-13 Accept <br> </span>, beContent=phosphoakt 2018-03-02 发表:: 研究方向:Prostate cancer;CRPC; 接收率:约50% 审稿时间:约1个月 2017-11-10 Submit 2017-11-26 Revision needed 2017-12-25 Submit Revision 2018-01-09 Revision needed 2018-02-05 Submit Revision 2018-02-13 Accept , objectType=tool_impact_factor, channel=null, level=null, likeNumber=369, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/249E70925AD389DC8D4E85A35F4AD5EB/100, createdBy=f9401983263, createdName=Hardy-Tau, createdTime=Mon Mar 26 00:00:00 CST 2018, time=2018-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553192, encodeId=1af4553192e3, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：2017-11-10 Submit <br> 2017-11-26 Revision needed <br> 2017-12-25 Submit Revision <br> 2018-01-09 Revision needed <br> 2018-02-05 Submit Revision <br> 2018-02-13 Accept <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=375, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f7ab1630245, createdName=phosphoakt, createdTime=Fri Mar 02 09:10:00 CST 2018, time=2018-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550869, encodeId=d77d5508691d, content=哪位战友知道一审多久吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=445, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/9aLK9Cx6dzdKJ7lWW1cTS61MIc1v1CV2y7jicQ7liaLlkspvBWzGvJrpsicQKxVxuYBnqJysMBlkoI5rtwF2YwCrw/132, createdBy=64631946589, createdName=泌外大主任, createdTime=Sun Jan 07 00:00:00 CST 2018, time=2018-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550487, encodeId=c58d55048e33, content=明年IF是不是要上20了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=326, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/41f5e204935a9288279aa6f69fffe8bc/32e5233dfd4cc36fb9489374ebbfc9e8.jpg, createdBy=ad821409331, createdName=liji_mike, createdTime=Sat Dec 30 18:38:00 CST 2017, time=2017-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544475, encodeId=5fd95444e520, content=谁能预测明年会有多少分?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=407, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=gu_8183, createdTime=Sun Jul 16 19:15:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=496443, encodeId=685c49644399, content=突破十分！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=519, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Jun 20 12:24:00 CST 2013, time=2013-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=493819, encodeId=0e5b4938197d, content=投稿9天就被拒，4个审稿专家，要求确实太高了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=501, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=wangyi, createdTime=Wed Feb 06 17:16:00 CST 2013, time=2013-02-06, status=1, ipAttribution=)]
    2013-02-06 wangyi

    投稿9天就被拒，4个审稿专家，要求确实太高了！

    0

共25条页码: 2/3页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分